コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 gs to a class of drugs recently described as selective estrogen receptor modulators.
2 PPARgamma and retinoid X receptor alpha with selective estrogen receptor modulators.
3 es are classified as both phytoestrogens and selective estrogen receptor modulators.
4 genic/estrogenic actions, characteristics of selective estrogen receptor modulators.
5 ed estrogenic and antiestrogenic activity of selective estrogen receptor modulators.
6 breast cancer are associated with the use of selective estrogen receptor modulators.
8 onal activity of ERalpha can be regulated by selective estrogen receptor modulators, a new class of d
9 photoreceptor degeneration that tamoxifen, a selective estrogen receptor modulator and a drug previou
12 method for the determination of idoxifene, a selective estrogen receptor modulator, and its pyrrolidi
13 de the mild androgen dehydroepiandrosterone, selective estrogen receptor modulators, and the prolacti
18 he altered (i.e., agonistic) pharmacology of selective estrogen receptor modulator drugs in this path
19 like action at activating function 2b of the selective estrogen receptor modulator ERalpha complex.
20 strates a novel allosteric mechanism for the selective estrogen receptor modulator ERalpha complex.
21 in regulating the estrogen-like activity of selective estrogen receptor modulator-ERalpha complexes.
23 Heart (RUTH) trial showed that raloxifene, a selective estrogen receptor modulator, had no overall ef
25 at mechanistic differences between different selective estrogen receptor modulators have been transla
27 benefits in the brain, including the use of selective estrogen receptor modulators, high soy diets,
29 a and ERbeta and differentially regulated by selective estrogen receptor modulators in a cell line-de
30 micked by the membrane impermeant E2-BSA and selective estrogen receptor modulators, including a new
33 contrast, raloxifene (Ral), which is also a selective estrogen receptor modulator, is a complete ant
37 dy designed to test the ability of the novel selective estrogen receptor modulator lasofoxifene (LAS)
40 te the therapeutic potential of tamoxifen, a selective estrogen receptor modulator, on estrogen-induc
41 dy was to examine the effects of LY117018, a selective estrogen receptor modulator, on peripheral ner
43 We evaluated the effects of toremifene, a selective estrogen-receptor modulator, on fasting serum
44 es of AIs in combination with more effective selective estrogen receptor modulators or selective rece
46 , our laboratory reported that raloxifene, a selective estrogen receptor modulator, promoted regressi
51 ith raloxifene, tamoxifen, and nonusers of a selective estrogen receptor modulator (SERM) in the gene
52 triphenylethylene bisphenol analogues of the selective estrogen receptor modulator (SERM) tamoxifen w
54 Bazedoxifene (BZA) is a third-generation selective estrogen receptor modulator (SERM) that has be
55 2-(4-methoxyphenyl)]be nzo[b]thiophene) is a selective estrogen receptor modulator (SERM) that is a p
56 sterone) replacement therapy (CRT) (n = 16), selective estrogen receptor modulator (SERM) therapy (n
57 The 2-arylbenzothiophene raloxifene, 1, is a selective estrogen receptor modulator (SERM) which is cu
60 ivities of SP500263, a novel next-generation selective estrogen receptor modulator (SERM), tamoxifen,
61 en, a breast cancer therapeutic, is a tissue-selective estrogen receptor modulator (SERM), which acts
62 353381.HCl-a novel, potent, third-generation selective estrogen receptor modulator (SERM)-because thi
66 y agonists, but surprisingly antagonists and selective estrogen receptor modulators (SERMs) activated
67 e most significant recent findings regarding selective estrogen receptor modulators (SERMs) and selec
68 d with adjuvant endocrine therapy, including selective estrogen receptor modulators (SERMs) and/or ar
71 scriptional activity of natural estrogens or selective estrogen receptor modulators (SERMs) has not b
76 of estrogenic and antiestrogenic effects of selective estrogen receptor modulators (SERMs) is though
78 Very little is known about the impact of selective estrogen receptor modulators (SERMs) on the br
81 s of estrogen's action and determine whether selective estrogen receptor modulators (SERMs) such as t
83 section of the mechanism(s) of action of the Selective Estrogen Receptor Modulators (SERMs) tamoxifen
84 resentative of a class of compounds known as selective estrogen receptor modulators (SERMs) that poss
87 bone in the ovariectomized rat by estrogen, selective estrogen receptor modulators (SERMs), and bisp
88 art of a program aimed at the development of selective estrogen receptor modulators (SERMs), novel ch
95 it estrogen action at the estrogen receptor (selective estrogen receptor modulators (SERMs]); or (2)
96 romatin is a key determinant of estrogen and selective estrogen receptor modulator signaling in the E
97 hydroxy-phenyl)-propionitrile (DPN), and the selective estrogen receptor modulator tamoxifen (Tam), i
98 ells, and promoted hormone resistance to the selective estrogen receptor modulator tamoxifen and sele
104 the risk for breast cancer-specifically, the selective estrogen receptor modulators tamoxifen and ral
106 ed the effects on uterine development of the selective estrogen receptor modulators, tamoxifen, torem
112 Arzoxifene and TSE-424 are investigational selective estrogen receptor modulators that have been sh
113 In addition, tamoxifen and raloxifene, two selective estrogen receptor modulators that have protect
115 aromatase inhibitors, fenretinide, or other selective estrogen receptor modulators to lower BC risk
116 hly facilitate the design of tissue-specific selective estrogen receptor modulators to treat breast c
117 , whereas the ERbeta-mediated agonism of all selective estrogen receptor modulators was present.
118 The 2-arylbenzothiophene raloxifene, 1, is a selective estrogen receptor modulator which is currently
120 d use of well defined forms of estrogens and selective estrogen receptor modulators will continue to
121 pha actions may provide means to develop new selective estrogen receptor modulators with improved pro
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。